Free Trial

The Biotech Growth Trust (BIOG) Competitors

The Biotech Growth Trust logo
GBX 970 +16.00 (+1.68%)
As of 11:52 AM Eastern

BIOG vs. JEO, MUT, APEO, ICGT, TFIF, RICA, SDP, SAIN, SLPE, and CGT

Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include European Opportunities Trust (JEO), Murray Income Trust (MUT), abrdn Private Equity Opportunities (APEO), ICG Enterprise Trust (ICGT), TwentyFour Income (TFIF), Ruffer Investment (RICA), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), Scottish American Investment (SAIN), Standard Life Private Equity Trust (SLPE), and Capital Gearing (CGT). These companies are all part of the "asset management" industry.

The Biotech Growth Trust vs. Its Competitors

European Opportunities Trust (LON:JEO) and The Biotech Growth Trust (LON:BIOG) are both small-cap asset management industry companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

10.5% of The Biotech Growth Trust shares are held by institutional investors. 2.4% of The Biotech Growth Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

The Biotech Growth Trust has lower revenue, but higher earnings than European Opportunities Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than European Opportunities Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Opportunities Trust-£62.33M0.00N/A-£65.20N/A
The Biotech Growth Trust-£78.81M-2.94£83.83M-£2.62-369.81

In the previous week, The Biotech Growth Trust had 1 more articles in the media than European Opportunities Trust. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for European Opportunities Trust. The Biotech Growth Trust's average media sentiment score of 1.42 beat European Opportunities Trust's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.

Company Overall Sentiment
European Opportunities Trust Neutral
The Biotech Growth Trust Positive

The Biotech Growth Trust has a net margin of 95.33% compared to European Opportunities Trust's net margin of 0.00%. The Biotech Growth Trust's return on equity of 26.96% beat European Opportunities Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
European Opportunities TrustN/A N/A N/A
The Biotech Growth Trust 95.33%26.96%12.39%

Summary

The Biotech Growth Trust beats European Opportunities Trust on 8 of the 10 factors compared between the two stocks.

Get The Biotech Growth Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIOG vs. The Competition

MetricThe Biotech Growth TrustAsset Management IndustryFinancial SectorLON Exchange
Market Cap£231.31M£1.49B£6.46B£2.60B
Dividend YieldN/A4.60%4.31%5.32%
P/E Ratio-369.814,731.421,778.555,398.40
Price / Sales-2.941,968.421,363.6897,640.86
Price / Cash87.7460.4749.0227.93
Price / Book0.901.362.108.91
Net Income£83.83M£264.59M£1.23B£5.89B
7 Day Performance5.90%0.13%1.44%0.56%
1 Month Performance8.99%1.07%2.69%2.72%
1 Year Performance-8.32%9.14%34.89%198.81%

The Biotech Growth Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIOG
The Biotech Growth Trust
N/AGBX 970
+1.7%
N/A-9.8%£231.31M-£78.81M-369.81N/APositive News
JEO
European Opportunities Trust
N/AN/AN/AN/A£886.70M-£62.33M-12.93N/A
MUT
Murray Income Trust
N/AGBX 900
+0.4%
N/A+3.5%£881.03M£27.79M3,703.70147,000Positive News
Dividend Cut
APEO
abrdn Private Equity Opportunities
N/AN/AN/AN/A£880.29M£80.21M1,435.00N/A
ICGT
ICG Enterprise Trust
N/AGBX 1,396
-0.4%
N/A+18.7%£877.72M£117.70M852.21N/A
TFIF
TwentyFour Income
N/AGBX 113
-0.4%
N/A+6.2%£869.01M£106.24M807.14N/A
RICA
Ruffer Investment
N/AGBX 288.50
+0.7%
N/A+4.4%£859.96M-£2.33M-20,034.72N/A
SDP
Schroder Investment Trust - Schroder AsiaPacific Fund
N/AGBX 635
+0.5%
N/A+23.6%£859.92M£55.98M2,003.79N/APositive News
SAIN
Scottish American Investment
N/AGBX 505
-0.8%
N/A-0.4%£854.76M£13.77M8,875.22N/A
SLPE
Standard Life Private Equity Trust
N/AGBX 555
+0.2%
N/A+1.7%£853.29M£289.51M298.07N/A
CGT
Capital Gearing
N/AGBX 4,865
flat
N/A+1.9%£818.73M£37.55M2,705.78N/A

Related Companies and Tools


This page (LON:BIOG) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners